Blake Anderson
Overview
Dr. Anderson is an assistant professor in the Division of General Internal Medicine. He is a faculty member of the Emory Clinical Informatics Fellowship. He is the founder and CEO of a healthcare technology company called Switchboard, MD that seeks to reduce inefficiencies in the operational aspects of healthcare.
Leadership: Dr. Anderson was the Chief Health Informatics Officer at the Atlanta VA Medical Center from 2021-2024 and served as Senior Medical Advisor to the VHA Office of Integrated Veteran Care from 8/2023-5/2024.
Training: Dr. Anderson received his MD from Emory University Medical School (2011). Dr. Anderson completed internal medicine residency followed by Chief Resident for Quality and Patient Safety at Emory University before joining in 2016 as a full-time faculty member.
Research: Dr. Andersons research program focuses on optimizing the intersection between data and computer systems and clinicians. He has a particular focus on natural language processing and predictive models. He has funding from HHS and AHRQ.
Patient care: Dr. Anderson practices at the Emory at Peachtree Hills Clinic. He is board certified in internal medicine.
Education
Degrees
- MD from Emory University School of Medicine
Research
Publications
-
Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study.
Clin Microbiol Infect Volume: 30 Page(s): 1599 - 1605
12/01/2024 Authors: Swank Z; Borberg E; Chen Y; Senussi Y; Chalise S; Manickas-Hill Z; Yu XG; Li JZ; Alter G; Henrich TJ -
Favorable Antiviral Effect of Metformin on SARS-CoV-2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of COVID-19.
Clin Infect Dis Volume: 79 Page(s): 354 - 363
08/16/2024 Authors: Bramante CT; Beckman KB; Mehta T; Karger AB; Odde DJ; Tignanelli CJ; Buse JB; Johnson DM; Watson RHB; Daniel JJ -
N-glycosylation of the SARS-CoV-2 spike protein at Asn331 and Asn343 is involved in spike-ACE2 binding, virus entry, and regulation of IL-6.
Microbiol Immunol Volume: 68 Page(s): 165 - 178
05/01/2024 Authors: Das T; Luo S; Tang H; Fang J; Mao Y; Yen H-H; Dash S; Shajahan A; Pepi L; Huang S -
Graph theoretic visualization of patient and health worker messaging in the EHR.
Front Artif Intell Volume: 7 Page(s): 1422208
01/01/2024 Authors: Zia Ul Haq M; Hornback A; Harzand A; Gutman DA; Gallaher B; Schoenberg ED; Zhu Y; Wang MD; Anderson B -
Early and fair COVID-19 outcome risk assessment using robust feature selection.
Sci Rep Volume: 13 Page(s): 18981
11/03/2023 Authors: Giuste FO; He L; Lais P; Shi W; Zhu Y; Hornback A; Tsai C; Isgut M; Anderson B; Wang MD -
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial.
Lancet Infect Dis Volume: 23 Page(s): 1119 - 1129
10/01/2023 Authors: Bramante CT; Buse JB; Liebovitz DM; Nicklas JM; Puskarich MA; Cohen K; Belani HK; Anderson BJ; Huling JD; Tignanelli CJ -
Use of Natural Language Processing of Patient-Initiated Electronic Health Record Messages to Identify Patients With COVID-19 Infection.
JAMA Netw Open Volume: 6 Page(s): e2322299
07/03/2023 Authors: Mermin-Bunnell K; Zhu Y; Hornback A; Damhorst G; Walker T; Robichaux C; Mathew L; Jaquemet N; Peters K; Johnson TM -
Metformin reduces SARS-CoV-2 in a Phase 3 Randomized Placebo Controlled Clinical Trial.
medRxiv
06/07/2023 Authors: Bramante CT; Beckman KB; Mehta T; Karger AB; Odde DJ; Tignanelli CJ; Buse JB; Johnson DM; Watson RHB; Daniel JJ -
Strategies used for the COVID-OUT decentralized trial of outpatient treatment of SARS-CoV-2.
J Clin Transl Sci Volume: 7 Page(s): e242
01/01/2023 Authors: Avula N; Kakach D; Tignanelli CJ; Liebovitz DM; Nicklas JM; Cohen K; Puskarich MA; Belani HK; Buse JB; Klatt NR -
Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up.
medRxiv
12/23/2022 Authors: Bramante CT; Buse JB; Liebovitz D; Nicklas J; Puskarich MA; Cohen K; Belani H; Anderson B; Huling JD; Tignanelli C